Literature DB >> 16586547

Morphological observation of tumor infiltrating immunocytes in human rectal cancer.

Zun-Jiang Xie1, Li-Min Jia, Ye-Chun He, Jiang-Tao Gao.   

Abstract

AIM: To investigate the morphological characterization of tumor infiltrating dendritic cells (TIDCs) and tumor infiltrating lymphocytes (TILs) in human rectal cancer.
METHODS: Light and electron microscopy as well as immunohistochemistry were used to observe the distributive and morphological changes of TIDCs and TILs.
RESULTS: TIDCs were mainly located in tumor-surrounding tissue. The number of TIDCs in the earlier stage was higher than that in the later stage (P<0.01). TILs were mainly seen in adjacent tissue of cancers and tumor-surrounding tissue. There were more TILs in the earlier stage than that in the later stage (P<0.01). Under electron microscope, TIDCs were irregular in shape and exhibited many dendritic protrusions. It is not obvious that cancer cells perforated the basement membrane and TILs were arranged along the basement membrane in the earlier stage. In the later stage, it is explicit that cancer cells perforated the basement membrane and surrounded by TILs. There were contacts among TIDCs, TILs and tumor cell. One TIDCs contacted one or several TILs which clustered around TIDCs. Glycogen granules were seen between TIDCs and TILs.
CONCLUSION: The number of TIDCs and TILs is related with tumor progression There exist close relationships among TIDCs, TILs and tumor cell.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16586547      PMCID: PMC4124353          DOI: 10.3748/wjg.v12.i11.1757

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

1.  Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery.

Authors:  W Asavaroengchai; Y Kotera; J J Mulé
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

Review 2.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

3.  Dendritic cells injected via different routes induce immunity in cancer patients.

Authors:  L Fong; D Brockstedt; C Benike; L Wu; E G Engleman
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

Review 4.  Physiology and pathophysiology of dendritic cells.

Authors:  V Wright-Browne; K L McClain; M Talpaz; N Ordonez; Z Estrov
Journal:  Hum Pathol       Date:  1997-05       Impact factor: 3.466

5.  Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells.

Authors:  C C Norbury; B J Chambers; A R Prescott; H G Ljunggren; C Watts
Journal:  Eur J Immunol       Date:  1997-01       Impact factor: 5.532

6.  Combined intratumoral injection of bone marrow-derived dendritic cells and systemic chemotherapy to treat pre-existing murine tumors.

Authors:  Y Tong; W Song; R G Crystal
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

7.  Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.

Authors:  Takayoshi Murakami; Naoyuki Tokunaga; Toshihiko Waku; Shinya Gomi; Shunsuke Kagawa; Noriaki Tanaka; Toshiyoshi Fujiwara
Journal:  Clin Cancer Res       Date:  2004-06-01       Impact factor: 12.531

8.  Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma.

Authors:  Mojgan Movassagh; Alain Spatz; Jean Davoust; Serge Lebecque; Pedro Romero; Mikaël Pittet; Donata Rimoldi; Danièle Liénard; Oliver Gugerli; Laurent Ferradini; Caroline Robert; Marie-Françoise Avril; Laurence Zitvogel; Eric Angevin
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

Review 9.  Dendritic cells as adjuvants for immune-mediated resistance to tumors.

Authors:  G Schuler; R M Steinman
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

10.  Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution.

Authors:  R M Steinman; Z A Cohn
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

View more
  9 in total

1.  Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer.

Authors:  Rui-Qing Peng; Ying-Bo Chen; Ya Ding; Rong Zhang; Xing Zhang; Xing-Juan Yu; Zhi-Wei Zhou; Yi-Xin Zeng; Xiao-Shi Zhang
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

2.  Role of dendritic cells in progression and clinical outcome of colon cancer.

Authors:  Maya V Gulubova; Julian R Ananiev; Tatyana I Vlaykova; Yovcho Yovchev; Vanya Tsoneva; Irena M Manolova
Journal:  Int J Colorectal Dis       Date:  2011-11-09       Impact factor: 2.571

3.  Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

Review 4.  Prognostic value of innate and adaptive immunity in colorectal cancer.

Authors:  Fabio Grizzi; Paolo Bianchi; Alberto Malesci; Luigi Laghi
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

5.  Heparanase expression, degradation of basement membrane and low degree of infiltration by immunocytes correlate with invasion and progression of human gastric cancer.

Authors:  Zun-Jiang Xie; Ying Liu; Li-Min Jia; Ye-Chun He
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

Review 6.  Dual Functional Capability of Dendritic Cells - Cytokine-Induced Killer Cells in Improving Side Effects of Colorectal Cancer Therapy.

Authors:  Paula Mosińska; Agata Gabryelska; Malwina Zasada; Jakub Fichna
Journal:  Front Pharmacol       Date:  2017-03-14       Impact factor: 5.810

Review 7.  Systemic Interleukins' Profile in Early and Advanced Colorectal Cancer.

Authors:  Paulina Czajka-Francuz; Sylwia Cisoń-Jurek; Aleksander Czajka; Maciej Kozaczka; Jerzy Wojnar; Jerzy Chudek; Tomasz Francuz
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

8.  The Prediction of Necroptosis-Related lncRNAs in Prognosis and Anticancer Therapy of Colorectal Cancer.

Authors:  Hanyu Xiao; Qidan Pang; Yong Wang; Suhe Lai; Hong Chen
Journal:  Anal Cell Pathol (Amst)       Date:  2022-09-23       Impact factor: 4.133

Review 9.  Dendritic cell defects in the colorectal cancer.

Authors:  Annalisa Legitimo; Rita Consolini; Alessandra Failli; Giulia Orsini; Roberto Spisni
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.